The minimal effective dose of thyroxine is increased in hypothyroid patients with ulcerative colitis

2019 ◽  
Author(s):  
Camilla Virili ◽  
Ilaria Stramazzo ◽  
Maria Giulia Santaguida ◽  
Lucilla Gargano ◽  
Marco Centanni
Thyroid ◽  
1991 ◽  
Vol 1 (2) ◽  
pp. 143-146 ◽  
Author(s):  
DER-CHUNG SHEN ◽  
SING-YUNG WU ◽  
INDER J. CHOPRA ◽  
LEE-REN SHIAN ◽  
WARNER FLORSHEIM ◽  
...  

1977 ◽  
Vol 232 (4) ◽  
pp. E353
Author(s):  
D Rudman ◽  
B M Hollins ◽  
N C Lewis ◽  
J W Scott

Choroid plexus of rabbit and rat was incubated for 2-30 min at 37 degrees C under 95% O2-5% CO2 in Tyrode solution containing 10 mM glucose and 1 mM theophylline with these agents: epinephrine, norepinephrine, isoproterenol, dopamine, histamine, serotonin, arginine, and lysine vasopressins, oxytocin, angiotensin, adrenocorticotropin (ACTH), beta-melanocyte-stimulating hormone, and choroid plexus peptide IIF. After incubation, tissue and medium were analyzed for 3', 5' -cyclic adenosine monophosphate (cAMP) content. Each amine or peptide was tested initially at 1,000 microng/ml. Only ACTH and serotonin affected cAMP content of rabbit choroid plexus. At 1,000 microng/ml, these agents caused a 10 and 4 times (respectively) increase in cAMP content of tissue + medium at 2-10 min with decline in content at 10-30 min. More than 90% of the increment was located in tissue, less than 10% in medium. Minimal effective dose (MED) to cause a significant (P less than .05) accumulation of cAMP was 0.1 microng/ml (2.2 x 10(-8) M) for ACTH and 10 microng/ml (5.7 x10(-3) M) for serotonin. Only isoproterenol, epinephrine, and norepinephrine influenced cAMP content of rat choroid plexus. MED's for this effect by isoproterenol, epinephrine, and norepinephrine were .001, .01, and 10 microng/ml (4.7 x 10(-9), 5.5 x 10(-8), and 5.9 x 10(-5) M), respectively.


Medicine ◽  
2017 ◽  
Vol 96 (9) ◽  
pp. e6149
Author(s):  
Sang Chul Lee ◽  
Hyun Seung Jin ◽  
Young Joo ◽  
Yong Chul Kim ◽  
Jee Youn Moon

1996 ◽  
Vol 4 (2) ◽  
pp. 218-223 ◽  
Author(s):  
James M. Swanson ◽  
Diane L. Christian ◽  
Tim Wigal ◽  
Walter Clevenger ◽  
Kimberly Fulbright Cavoto ◽  
...  

2011 ◽  
Vol 4;14 (4;7) ◽  
pp. 361-370
Author(s):  
Byeong Mun Hwang

Background: Intervertebral disc herniations are the most common cause of lumbosacral radiculopathy, and transforaminal epidural steroid injection (TFESI) is an important tool in treating lumbosacral radiculopathy. But the ideal dose of corticosteroid in the epidural management of lumbosacral radiculopathy has yet to be determined. Objective: The aim of this study was to determine the effective dose of steroids in TFESI for pain reduction in patients with lumbosacral radiculopathy. Study Design: A randomized, double blind, controlled trial Setting: An interventional pain management practice center. Methods: A total of 160 participants received 2 epidural injections of either 5 mg, 10 mg, 20 mg, or 40 mg of triamcinolone in one week intervals via TFESI. The degree of participant satisfaction and verbal numerical rating scale (VNRS) were assessed at pretreatment, one week, and 2 weeks after the first TFESI. Results: The number of participants experiencing pain relief was significantly less than in other groups in the 5 mg triamcinolone group at one week after the first TFESI. There were no significant differences among the groups at one week after the second TFESI. VNRS decreased in the other groups except the triamcinolone 5 mg group at one week after the first TFESI. VNRS decreased in all groups at one week after the second TFESI. Limitations: The limitations include lack of placebo control group and lack of long-term follow-up. Conclusions: We recommend a minimal effective dose of corticosteroid (triamcinolone 10 mg) in TFESI for patients with lumbosacral radiculopathy. Key words: herniated disc, steroid, transforaminal epidural steroid injection, triamcinolone


Sign in / Sign up

Export Citation Format

Share Document